Algiax Pharmaceuticals

Private

DusseldorfHealthcare & Life Scienceshttps://www.algiax.com/

Last Round

VC Round

Dec 9, 2019

Total Funding Raised

$5.53M

Company Overview

Algiax Pharmaceuticals is a clinical-stage biotechnology company that develops innovative small-molecule therapeutics for the treatment of chronic neuropathic pain and other diseases with high unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryneuropathic painsmall moleculeclinical-stage biotechCNS disordersnon-opioidclinical trialsbiotech startupdrug developmentcontract research organizationCROpharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Algiax Pharmaceuticals Comparables

Compare Algiax Pharmaceuticals with similar companies based on industry and business-model similarity.

Algiax Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Artelo Biosciences, Inc.	78%
Dogwood Therapeutics, Inc.	77%
Asahi Kasei	72%

View all Comparables

Algiax Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 9, 2019
Series A	May 14, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Ingo Lehrke

Chief Executive Officer

Executive Team

Algiax Pharmaceuticals Investors

Notable investors and investment history

Algiax Pharmaceuticals investors
Investor	Rounds
KfW Development Bank	Series A
High-Tech Gründerfonds	Series A
OCCIDENT	VC Round

View all Investors

Algiax Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Algiax Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Algiax Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersDusseldorf

Employee Range5

Year Founded2011

Last FundingDec 9, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.